PA
QXO

PharVision Advisers’s QXO Inc QXO Stock Holding History

PharVision Advisers’s Portfolio QXO Stock Details QXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-9,452
Closed -$204K – 824
2025
Q2 		$204K Buy
+9,452
New +$155K 0.29% 202

Other funds holding QXO

OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AP
Affinity Partners Sunny Isles Beach, Florida $635M AUM 43.43% 1-Year Est. Return
AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
SG
SCHF (GPE) Wilson, Wyoming $781M AUM 24.06% 1-Year Est. Return

PharVision Advisers's QXO Position: Q3 2025 in Review

PharVision Advisers sold out of QXO Inc (QXO) in Q3 2025, closing a stake of 9,452 shares — an estimated $204K sold.

PharVision Advisers first reported a position in QXO in Q2 2025 and held it in 1 quarter. The position peaked at $204K in Q2 2025. 475 funds tracked by Wall St. Rank hold QXO as of Q3 2025.

  • PharVision Advisers reported no remaining QXO Inc position as of Q3 2025 after selling out during the quarter.
  • PharVision Advisers sold 9,452 QXO Inc shares in Q3 2025, an estimated $204K.
  • PharVision Advisers first reported a position in QXO Inc in Q2 2025 and held it in 1 quarter.
  • PharVision Advisers's QXO Inc position peaked at $204K in Q2 2025.
  • 475 funds tracked by Wall St. Rank held QXO Inc as of Q3 2025.

Based on PharVision Advisers's 13F filing for Q3 2025, filed 17 Nov 2025.